Cargando…

Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies

Recent advances in inhaled drugs and a clearer definition of the disease have made the task of managing COPD more complex. Different proposals have been put forward which combine all the available treatments and the different clinical presentations in an effort to select the best therapeutic options...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Campos, Jose Luis, Carrasco Hernández, Laura, Ruiz-Duque, Borja, Reinoso-Arija, Rocio, Caballero-Eraso, Candelaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285922/
https://www.ncbi.nlm.nih.gov/pubmed/34285480
http://dx.doi.org/10.2147/COPD.S275943
_version_ 1783723643000324096
author López-Campos, Jose Luis
Carrasco Hernández, Laura
Ruiz-Duque, Borja
Reinoso-Arija, Rocio
Caballero-Eraso, Candelaria
author_facet López-Campos, Jose Luis
Carrasco Hernández, Laura
Ruiz-Duque, Borja
Reinoso-Arija, Rocio
Caballero-Eraso, Candelaria
author_sort López-Campos, Jose Luis
collection PubMed
description Recent advances in inhaled drugs and a clearer definition of the disease have made the task of managing COPD more complex. Different proposals have been put forward which combine all the available treatments and the different clinical presentations in an effort to select the best therapeutic options for each clinical context. As COPD is a chronic progressive disease, the escalation of therapy has traditionally been considered the most natural way to tackle it. However, the notion of COPD as a constantly progressing disease has recently been challenged and, in specific areas, this points to the possibility of a de-escalation in treatment. In this context, the clinician requires simple, specific recommendations to guide these changes in treatment in their daily clinical practice. To accomplish this, the first step must be a correct evaluation and an accurate initial preliminary diagnosis of the patient’s condition. Thereafter, the first escalation in therapy must be introduced with caution as the disease progresses, since clinical trials are not designed with clinical decision-making in mind. During this escalation, three possibilities are open to change the current treatment for a different one within the same family, to increase non-pharmacological interventions or to increase the pharmacological therapies. Beyond that point, a patient with persistent symptoms represents a complex clinical scenario which requires a specialized approach, including the evaluation of different respiratory and non-respiratory comorbidities. Unfortunately, there are few de-escalation studies available, and these are mainly observational in nature. The debate on de-escalation in pharmacological treatment, therefore, involves two main discussion points: the withdrawal of bronchodilators and the withdrawal of inhaled steroids. Altogether, the scheme for modifying treatment must be more personalized than just adding molecules, and the therapeutic response and its conditioning factors should be evaluated at each step before proceeding further.
format Online
Article
Text
id pubmed-8285922
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-82859222021-07-19 Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies López-Campos, Jose Luis Carrasco Hernández, Laura Ruiz-Duque, Borja Reinoso-Arija, Rocio Caballero-Eraso, Candelaria Int J Chron Obstruct Pulmon Dis Review Recent advances in inhaled drugs and a clearer definition of the disease have made the task of managing COPD more complex. Different proposals have been put forward which combine all the available treatments and the different clinical presentations in an effort to select the best therapeutic options for each clinical context. As COPD is a chronic progressive disease, the escalation of therapy has traditionally been considered the most natural way to tackle it. However, the notion of COPD as a constantly progressing disease has recently been challenged and, in specific areas, this points to the possibility of a de-escalation in treatment. In this context, the clinician requires simple, specific recommendations to guide these changes in treatment in their daily clinical practice. To accomplish this, the first step must be a correct evaluation and an accurate initial preliminary diagnosis of the patient’s condition. Thereafter, the first escalation in therapy must be introduced with caution as the disease progresses, since clinical trials are not designed with clinical decision-making in mind. During this escalation, three possibilities are open to change the current treatment for a different one within the same family, to increase non-pharmacological interventions or to increase the pharmacological therapies. Beyond that point, a patient with persistent symptoms represents a complex clinical scenario which requires a specialized approach, including the evaluation of different respiratory and non-respiratory comorbidities. Unfortunately, there are few de-escalation studies available, and these are mainly observational in nature. The debate on de-escalation in pharmacological treatment, therefore, involves two main discussion points: the withdrawal of bronchodilators and the withdrawal of inhaled steroids. Altogether, the scheme for modifying treatment must be more personalized than just adding molecules, and the therapeutic response and its conditioning factors should be evaluated at each step before proceeding further. Dove 2021-07-12 /pmc/articles/PMC8285922/ /pubmed/34285480 http://dx.doi.org/10.2147/COPD.S275943 Text en © 2021 López-Campos et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
López-Campos, Jose Luis
Carrasco Hernández, Laura
Ruiz-Duque, Borja
Reinoso-Arija, Rocio
Caballero-Eraso, Candelaria
Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies
title Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies
title_full Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies
title_fullStr Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies
title_full_unstemmed Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies
title_short Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies
title_sort step-up and step-down treatment approaches for copd: a holistic view of progressive therapies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285922/
https://www.ncbi.nlm.nih.gov/pubmed/34285480
http://dx.doi.org/10.2147/COPD.S275943
work_keys_str_mv AT lopezcamposjoseluis stepupandstepdowntreatmentapproachesforcopdaholisticviewofprogressivetherapies
AT carrascohernandezlaura stepupandstepdowntreatmentapproachesforcopdaholisticviewofprogressivetherapies
AT ruizduqueborja stepupandstepdowntreatmentapproachesforcopdaholisticviewofprogressivetherapies
AT reinosoarijarocio stepupandstepdowntreatmentapproachesforcopdaholisticviewofprogressivetherapies
AT caballeroerasocandelaria stepupandstepdowntreatmentapproachesforcopdaholisticviewofprogressivetherapies